1	ZHANG H, ZHAO S, ZHANG H, et al. Vaccines for African swine fever: an update[J/OL]. Frontiers in microbiology, 2023, 14: 1139494[2023-12-03]. https://doi.org/10.3389/fmicb.2023.1139494 本文引用 [1]

2

SUN H, NIU Q, YANG J, et al. Transcriptome profiling reveals features of immune response and metabolism of acutely infected, dead and asymptomatic infection of African swine fever virus in pigs[J/OL]. Frontiers in immunology, 2021,12:808545[2023-12-03]. https://doi.org/10.3389/fimmu.2021.808545 本文引用 [2]

3	ZHANG K, LI S, LIU S, et al. Spatiotemporally orchestrated interactions between viral and cellular proteins involved in the entry of African swine fever virus[J/OL]. Viruses, 2021, 13(12):2495[2023-12-03]. https://doi.org/10.3390/v13122495 本文引用 [2]

4	ATA EB, LI ZJ, SHI CW, et al. African swine fever virus: a raised global upsurge and a continuous threaten to pig husbandry[J/OL]. Microbial pathogenesis, 2022,167:105561[2023-12-03]. https://doi.org/10.1016/j.micpath.2022.105561 本文引用 [1]

5	MATAMOROS T, ALEJO A, RODRÍGUEZ JM, et al. African swine fever virus protein pE199L mediates virus entry by enabling membrane fusion and core penetration[J/OL]. mBio, 2020, 11(4):e00789-20[2023-12-03]. https://doi.org/10.1128/mBio.00789 本文引用 [1]

6	ALEJO A, MATAMOROS T, GUERRA M, et al. A proteomic atlas of the African swine fever virus particle[J/OL]. Journal of virology, 2018,92(23):e01293-18[2023-12-03]. https://doi.org/10.1128/JVI.01293-18 本文引用 [1]

7	LI G, LIU X, YANG M, et al. Crystal structure of African swine fever virus pS273R protease and implications for inhibitor design[J/OL]. Journal of virology, 2020, 94(10): e02125-19[2023-12-03]. https://doi.org/10.1128/JVI.02125-19 本文引用 [1]

8	YANG S, MIAO C, LIU W, et al. Structure and function of African swine fever virus proteins: current understanding[J/OL]. Frontiers in microbiology, 2023, 14:1043129[2023-12-03]. https://doi.org/10.3389/fmicb.2023.1043129 本文引用 [2]

9	EULÁLIO A, NUNES-CORREIA I, SALAS J, et al. African swine fever virus p37 structural protein is localized in nuclear foci containing the viral DNA at early post-infection times[J]. Virus research, 2007, 130(1/2):18-27. 本文引用 [1]

10	COELHO J, LEITÃO A. The African swine fever virus (ASFV) topoisomerase Ⅱ as a target for viral prevention and control[J/OL]. Vaccines, 2020,8(2):312[2023-12-03]. https://doi.org/10.3390/vaccines8020312 本文引用 [1]

11	RAMIREZ-MEDINA E, VUONO EA, PRUITT S, et al. Deletion of an African swine fever virus ATP-dependent RNA helicase QP509L from the highly virulent georgia 2010 strain does not affect replication or virulence[J/OL]. Viruses, 2022, 14(11):2548[2023-12-03]. https://doi.org/10.3390/v14112548 本文引用 [1]

12	DU X, GAO Z Q, GENG Z, et al. Structure and biochemical characteristic of the methyltransferase (MTase) domain of RNA capping enzyme from African swine fever virus[J/OL]. Journal of virology, 2021, 95(5): e02029-20[2023-12-03]. https://doi.org/10.1128/JVI.02029-20 本文引用 [1]

13	YANG Y, ZHANG C, LI X, et al. Structural insight into molecular inhibitory mechanism of InsP(6) on African swine fever virus mRNA-decapping enzyme g5Rp[J/OL]. Journal of virology, 2022, 96(10):e0190521[2023-12-03]. https://doi.org/10.1128/jvi.01905-21 本文引用 [1]

14	ROMAGNOLI A, D'AGOSTINO M, ARDICCIONI C, et al. Control of the eIF4E activity: structural insights and pharmacological implications[J]. Cellular and molecular life sciences: CMLS, 2021, 78(21-22):6869-6885. 本文引用 [1]

15

BARRADO-GIL L, DEL PUERTO A, MUÑOZ-MORENO R, et al. African swine fever virus ubiquitin-conjugating enzyme interacts with host translation machinery to regulate the host protein synthesis[J/OL]. Frontiers in microbiology, 2020, 11:622907[2023-12-03]. https://doi.org/10.3389/fmicb.2020.622907 本文引用 [1]

16	MENG K, ZHANG Y, LIU Q, et al. Structural design and assessing of recombinantly expressed African swine fever virus p72 trimer in Saccharomyces cerevisiae [J/OL]. Frontiers in microbiology, 2022, 13:802098[2023-12-03]. https://doi.org/10.3389/fmicb.2022.802098 本文引用 [1]

17	ANDRÉS G, CHARRO D, MATAMOROS T, et al. The cryo-EM structure of African swine fever virus unravels a unique architecture comprising two icosahedral protein capsids and two lipoprotein membranes[J]. The journal of biological chemistry, 2020, 295(1):1-12. 本文引用 [3]

18	MUÑOZ AL, TABARÉS E. Characteristics of the major structural proteins of African swine fever virus: role as antigens in the induction of neutralizing antibodies[J]. Virology, 2022, 571:46-51. 本文引用 [1]

19	ZHENG W, XIA N, ZHANG J, et al. African swine fever virus structural protein p17 inhibits cGAS-STING signaling pathway through interacting with STING[J/OL]. Frontiers in immunology, 2022,13:941579[2023-12-03]. https://doi.org/10.3389/fimmu.2022.941579 本文引用 [1]

20	XIA N, WANG H, LIU X, et al. African swine fever virus structural protein p17 inhibits cell proliferation through ER stress-ROS mediated cell cycle arrest[J/OL]. Viruses, 2020, 13(1): 21[2023-12-03]. https://doi.org/10.3390/v13010021 本文引用 [1]

21	TNG PYL, AL-ADWANI L, PAULETTO E, et al. Capsid-specific antibody responses of domestic pigs immunized with low-virulent African swine fever virus[J/OL]. Vaccines, 2023, 11(10):1577[2023-12-03]. https://doi.org/10.3390/vaccines11101577 本文引用 [1]

22	CADENAS-FERNÁNDEZ E, SÁNCHEZ-VIZCAÍNO JM, VAN DEN BORN E, et al. High doses of inactivated African swine fever virus are safe, but do not confer protection against a virulent challenge[J/OL]. Vaccines, 2021,9(3):242[2023-12-03]. https://doi.org/10.3390/vaccines9030242 本文引用 [1]

23	GÓMEZ-PUERTAS P, RODRÍGUEZ F, OVIEDO JM, et al. The African swine fever virus proteins p54 and p30 are involved in two distinct steps of virus attachment and both contribute to the antibody-mediated protective immune response[J]. Virology, 1998, 243(2):461-471. 本文引用 [1]

24	NEILAN JG, ZSAK L, LU Z, et al. Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection[J]. Virology, 2004, 319(2):337-342. 本文引用 [1]

25	LACASTA A, BALLESTER M, MONTEAGUDO PL, et al. Expression library immunization can confer protection against lethal challenge with African swine fever virus[J]. Journal of virology, 2014, 88(22):13322-13332. 本文引用 [2]

26	ARGILAGUET JM, PÉREZ-MARTÍN E, NOFRARÍAS M, et al. DNA vaccination partially protects against African swine fever virus lethal challenge in the absence of antibodies[J/OL]. PloS one, 2012, 7(9):e40942[2023-12-03]. https://doi.org/10.1371/journal.pone.0040942 本文引用 [1]

27	MURGIA MV, MOGLER M, CERTOMA A, et al. Evaluation of an African swine fever (ASF) vaccine strategy incorporating priming with an alphavirus-expressed antigen followed by boosting with attenuated ASF virus[J]. Archives of virology, 2019, 164(2):359-370. 本文引用 [1]

28	NETHERTON CL, GOATLEY LC, REIS AL, et al. Identification and immunogenicity of African swine fever virus antigens[J/OL]. Frontiers in immunology, 2019, 10:1318[2023-12-03]. https://doi.org/10.3389/fimmu.2019.01318 本文引用 [1]

29	LIU W, LI H, LIU B, et al. A new vaccination regimen using adenovirus-vectored vaccine confers effective protection against African swine fever virus in swine[J/OL]. Emerging microbes & infections, 2023,12(2):2233643[2023-12-03]. https://doi.org/10.1080/22221751.2023.2233643 本文引用 [1]

30	LIU L, WANG X, MAO R, et al. Research progress on live attenuated vaccine against African swine fever virus[J/OL]. Microbial pathogenesis, 2021, 158:105024[2023-12-03]. https://doi.org/10.1016/j.micpath.2021.105024 本文引用 [1]

31	BALYSHEVA V I, PRUDNIKOVA E Y, GALNBEK T V, et al. Immunological properties of attenuated variants of African swine fever virus isolated in the Russian Federation[J]. Veterinary science, 2015, 41(2/3):178-182. 本文引用 [1]

32	KING K, CHAPMAN D, ARGILAGUET JM, et al. Protection of European domestic pigs from virulent African isolates of African swine fever virus by experimental immunisation[J]. Vaccine, 2011, 29(28):4593-4600. 本文引用 [1]

33	ABKALLO H M, SVITEK N, ODUOR B, et al. Rapid CRISPR/Cas9 editing of genotype IX African swine fever virus circulating in eastern and central Africa[J/OL]. Frontiers in genetics, 2021, 12:733674[2023-12-03]. https://doi.org/10.3389/fgene.2021.733674 本文引用 [1]

34	BORCA M V, HOLINKA L G, BERGGREN K A, et al. CRISPR-Cas9, a tool to efficiently increase the development of recombinant African swine fever viruses[J/OL]. Scientific reports, 2018, 8(1):3154[2023-12-03]. https://doi.org/10.1038/s41598-018-21575-8 本文引用 [1]

35

VELAZQUEZ-SALINAS L, RAMIREZ-MEDINA E, RAI A, et al. Development real-time PCR assays to genetically differentiate vaccinated pigs from infected pigs with the eurasian strain of African swine fever virus[J/OL]. Frontiers in veterinary science, 2021, 8:768869[2023-12-03]. https://doi.org/10.3389/fvets.2021.768869 本文引用 [1]

36

BORCA M V, RAI A, ESPINOZA N, et al. African swine fever vaccine candidate ASFV-G-ΔI177L produced in the swine macrophage-derived cell line IPKM remains genetically stable and protective against homologous virulent challenge[J/OL]. Viruses, 2023, 15(10):2064[2023-12-03]. https://doi.org/10.3390/v15102064 本文引用 [1]

37	URBANO A C, FERREIRA F. African swine fever control and prevention: an update on vaccine development[J]. Emerging microbes & infections, 2022, 11(1):2021-2033. 本文引用 [1]

38	BARASONA JA, CADENAS-FERNÁNDEZ E, KOSOWSKA A, et al. Safety of African swine fever vaccine candidate Lv17/WB/rie1 in wild boar: overdose and repeated doses[J/OL]. Frontiers in immunology, 2021, 12:761753[2023-12-03]. https://doi.org/10.3389/fimmu.2021.761753 本文引用 [1]